Compound ID | 2939
Class: Drug efflux pump inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against Escherichia coli; efflux pump AcrB inhibitor |
| Description: | Synthetic compound; reduces MIC of several antibiotics (ex: oxacillin, pyridomycin, linezolid, novobiocin, fusidic acid, chloramphenicol); no intrinsic antibacterial activity |
| Institute where first reported: | Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019—UMR 9017—CIIL—Center for Infection and Immunity of Lille, F-59000 Lille, France |
| Year first mentioned: | 2022 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/153987774 |
| Citation: | https://www.nature.com/articles/s41467-021-27726-2 |